Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer

Fig. 4

The prognostic value of FR risk signature is validated in multiple cohorts. (A) Survival difference in GSE20685 cohort. (B) ROC curve in GSE20685 cohort. (C) Survival difference in GSE58812 cohort. (D) ROC curve in GSE58812 cohort. (E) Survival difference in IGCG-KR cohort. (F) ROC curve in ICGC-KR cohort. (G) Survival difference in METABRIC cohort. (H) ROC curve in METABRIC cohort. (I-M) The survival differences of patients with five molecular subtypes in METABRIC cohort. (N) The heatmap for FR gene expressions and clinical features in METABRIC cohort. FR, ferroptosis-related; ROC, receiver operating characteristic curve; * means P<0.05; ** means P<0.01

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us